Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Pimozide”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 145 records · Page 8Linked to original sources

Effects of pimozide on sucrose consumption and preference.

The effects of pimozide on sucrose intake were examined, in a two-bottle preference test (sucrose versus water), and in single-bottle tests at five different sucrose concentrations. In the two-bottle test, pimozide dose dependently decreased sucrose intake but increased water intake. In the single-bottle test pimozide decreased sucrose intake at low concentrations but had no effect at high concentrations. The results support a role for dopamine in mediating the rewarding effect of sucrose.

Animals↗

Gonadotropin production and release in female goldfish (Carassius auratus) after administration of pimozide and an LHRH analogue as studied by electron microscopy and radioimmunoassay.

The effect of pimozide and an LHRH-analogue (LHRH-A) on gonadotropic cells of the goldfish pituitary gland were described qualitatively and quantitatively. A scale of four categories was devised to reflect various ultrastructural appearances of the cells. Experimental animals were divided into a control group, a group injected with LHRH-A alone, pimozide alone, and groups receiving these two substances in combination. Fish injected with the single substance were killed 12 h after injection while the groups receiving the combined treatments were killed at 4, 12 and 48 h. Serum levels of gonadotropin measured by radioimmunoassay were used to indicate whether an increase in hormone release had occurred. An immunocytochemical technique, the protein A-gold procedure, assured that the cells studied were gonadotropes. The control group showed variation in the profiles of gonadotropic cells. The single treatment groups showed some increase in secretory inclusions. At 4 h after injection the combined treatment caused a significant increase in hormone granules; at 12 and 48 h there was a gradual decrease in content of secretory products, and an increase in vacuolization. The results indicate that the combined pimozide and LHRH-A treatment stimulated gonadotropin production as well as release.

Animals↗

Attenuation by pimozide of the suppressant effect of d-amphetamine on operant behaviour.

The interaction between pimozide (a selective D2-dopamine receptor antagonist) and d-amphetamine on the operant performance of rats maintained under variable-interval schedules of positive reinforcement was examined. In Experiment 1, eight rats responded under variable-interval 30-s and variable-interval 300-s. Pimozide (0.0625, 0.125, 0.25, 0.5 mg/kg) suppressed performance maintained under both schedules in a dose-dependent manner, the degrees of suppression being equivalent in the two schedules. In Experiment 2, 12 rats responded under the same schedules. d-Amphetamine (0.1-3.2 mg/kg) suppressed performance under both schedules, the degree of suppression being somewhat greater in the case of variable-interval 30-s. Pre-treatment with pimozide (0.0625, 0.125 mg/kg) significantly attenuated the suppressant effect of d-amphetamine under both schedules. It is suggested that D2-dopamine receptors may be involved in mediating the suppressant effect of d-amphetamine on operant behaviour.

Animals↗

Dopamine and mania: behavioral and biochemical effects of the dopamine receptor blocker pimozide.

Although recent data suggest that pimozide has effects at other neurotransmitter receptor sites, it is one of the more specific neuroleptics in its effects on dopamine receptors. We report that in manic patients pimozide produces substantial clinical improvement with a magnitude and time course similar to that observed with the more routinely used phenothiazines chlorpromazine and thioridazine. Pimozide did not significantly increase probenecid-induced accumulations of the dopamine metabolite homovanillic acid (HVA) compared to pretreatment values. Higher HVA values were observed in manic than in nonmanic patients, however. These clinical and biochemical data add to a growing body of indirect evidence that a dopaminergic alteration may be associated with some components of the manic syndrome.

Adult↗

The effect of pimozide on the establishment of conditioned reinforcement.

The effect of pimozide on conditioned reinforcement was determined by comparing rate of lever pressing for a tone in groups previously treated with or without the drug when the tone was paired with food. Eight groups of six to eight rats each received three phases of training in a two-lever box. The pre-exposure phase measured the operant rate of pressing the two levers, one of which produced a 3s tone. In the conditioning phase, with the levers absent, the tone was paired with food over four sessions. The test phase again measured the rate of pressing the two levers. In an undrugged experimental group (i.e., Paradigm group), the number of presses on the tone lever significantly increased from the pre-exposure to the test phase, thereby confirming that the procedure could establish conditioned reinforcement. A control group receiving tones and pellets randomly during the conditioning phase also showed conditioned reinforcement but a group receiving negatively correlated tones and pellets did not. Groups receiving the dopamine-receptor blocker pimozide (1.0 mg/kg) prior to each conditioning session failed to show conditioned reinforcement in the test session. Control groups ruled out state dependent learning and drug-induced performance impairments as explanations of this pimozide-related effect. These data may indicate a possible role for dopamine neurons in mediating the control of behavior by certain positive reinforcing stimuli.

Animals↗

The effect of haloperidol, spiperone and pimozide on the flexor reflex of the hind limb of the spinal rat.

It was found that spiperone and pimozide in doses which themselves do not influence the flexor reflex of the hind limb of the spinal rat inhibit stimulation of this reflex induced by serotoninomimetic drugs (LSD and fenfluramine). Higher doses of spiperone depress the flexor reflex and inhibit the stimulating effect of clonidine. Pimozide has no such effect. Haloperidol in doses which do not influence the action of LSD and fenfluramine produces a depression of the flexor reflex and antagonizes the action of clonidine. Our findings indicate that, irrespective of their antidopamine action, spiperone has a central antiserotonin effect and an antinoradrenaline one, pimozide--an antiserotonin one and haloperidol--an antinoradrenaline one.

Animals↗

Effects of pimozide, across doses and within sessions, on discriminated lever release performance in rats.

By using either water or food reinforcement, rats were trained to perform a discriminated lever release task (DLR), which required the rat to hold an operant lever in the closed position through one of five randomly presented foreperiods (2-6 s) and to release the lever within 0.5 s of the onset of a light discriminative stimulus. The procedure is analogous to the method used in human reaction time studies, except that here the procedure was free-operant, not fixed-trial. The effects of pimozide (0.12, 0.25, and 0.50 mg/kg) on this behavior were evaluated in terms of numbers of total responses, reinforced responses (successful releases), anticipatory responses, and extended responses (holding too long). Significant dose-dependent decreases in total responses and in reinforced responses were seen as supporting the hypothesis of a deficit in response initiation, which is often invoked to account for neuroleptic-induced reductions in discriminated active avoidance. Pimozide also increased the proportion of extended responses, suggesting that the drug affected the nature of responding as well as the tendency to respond. In the DLR task, pimozide produced substantial within-session decrements in both total responses and number of reinforced responses; however, extended responses exhibited within-session increases at the lowest dose. The results were discussed from both behavioral and pharmacological perspectives. The former emphasized motor effects and response initiation deficits, while the latter jointly considered neuronal responses to neuroleptic challenge and the dopamine release that results from behavioral activity itself.

Animals↗

Differential modulation of dopamine D2 receptors by chronic haloperidol, nitrendipine, and pimozide.

Chronic administration of the neuroleptic haloperidol, the calcium channel antagonist nitrendipine, and the calcium channel antagonist neuroleptic pimozide produce differential effects on rat striatal 3H-spiperone binding. Following 7 days of 10 mg/kg i.p. administration, haloperidol significantly increases (p less than 0.01) dopamine D2 receptor binding to 123% +/- 6% of control values, whereas pimozide treatment significantly reduces (p less than 0.001) striatal 3H-spiperone binding to 46% +/- 6% of control values. Chronic administration of the calcium channel antagonist nitrendipine does not alter 3H-spiperone binding relative to control values. Saturation analysis reveals an increase in Bmax following chronic haloperidol and a decrease in Bmax following chronic pimozide treatment. No alterations in muscarinic cholinergic sites, dopamine uptake sites, or calcium channel antagonist sites result following chronic drug administration. These results are the first demonstration of a decrease in dopamine D2 binding sites after chronic neuroleptic treatment.

Animals↗

Effects of pimozide and naloxone on latency for hypothalamically induced eating.

Latency to feed in response to lateral hypothalamic electrical stimulation was assessed at a variety of stimulation frequencies using moderate stimulation intensity; shorter latencies accompanied higher stimulation frequencies. Pimozide (0.0625, 0.125, 0.25 and 0.5 mg/kg, i.p.) and naloxone (0.5, 1.0, 2.0 and 4.0 mg/kg, i.p.) increased latencies in a dose-dependent manner. At 0.5 mg/kg (4 X the lowest effective dose), pimozide blocked eating completely for most trials and in all animals. Naloxone attenuated eating at 1.0 mg/kg, but 4.0 mg/kg was not more effective than 2.0 mg/kg and did not block the behavior completely in any animal. With each drug, latencies were normal or near-normal at the beginning of each session and anorexic effects developed with repeated testing. Thus neither drug caused a simple overall impairment in performance capability. In both cases it is inferred that the proximal food cues lost the ability to maintain eating well before the distal food cues lost the ability to elicit eating. The similarity between the effects of pimozide and naloxone raises the possibility that opioid-containing and dopamine-containing neurons interact to influence feeding through common brain circuitry.

Animals↗

Effects of pimozide on the response of smooth muscle to non-dopamine agonists and calcium.

Pimozide inhibits acetylcholine and histamine-induced contractions of the isolated guinea-pig ileum and noradrenaline-induced contractions of the isolated rat vas deferens in a non-competitive manner. In order to explore the nature of this inhibitory effect, we investigated pimozide's effects on calcium-induced contractions of deplorized guinea-pig ileum. In this case the antagonism elicited was competitive. Therefore caution is indicated in the use of pimozide to provide indirect proof of the existence of peripheral dopamine receptors.

Acetylcholine↗

Effect of haloperidol and pimozide on acetylcholine output from the cerebral cortex in rats and guinea pigs.

The effect of haloperidol, pimozide and amphetamine on acetylcholine (ACh) output from the cerebral cortex was investigated in unanaesthetized, freely moving and urethane-anaesthetized rats and guinea pigs. Haloperidol (1 mg/kg i.p.) decreased ACh output only in the anaesthetized rats and increased it only in unanaesthetized guinea pigs. Pimozide (1 mg/kg i.p.) stimulated ACh output in unanaesthetized rats and guinea pigs and anaesthetized guinea pigs, but not in anaesthetized rats. Amphetamine (1 mg/kg i.p.) in all cases, stimulated ACh output. In rats with a septal lesion, the effect of amphetamine on ACh output was suppressed but that of pimozide was still present.

Acetylcholine↗

Differential effects of pimozide and SCH 23390 on acquisition of learning in mice.

Our main purpose was to clarify the differences between the effects of dopamine D-1 (SCH 23390) and D-2 (pimozide) antagonists on memory acquisition in a water-finding and a one-trial passive avoidance task with ddY mice. In the water-finding task, pimozide (0.1 and 0.2 mg/kg i.p.) enhanced the acquisition of latent learning of mice although it suppressed exploratory behavior. In contrast, SCH 23390 (0.1 mg/kg i.p.) attenuated the acquisition of latent learning and suppressed exploratory behavior. In the passive avoidance task, pimozide (0.1 and 0.2 mg/kg i.p.) enhanced the acquisition of the passive avoidance response of mice. SCH 23390 (0.05 and 0.1 mg/kg i.p.) failed to enhance the acquisition of the passive avoidance response. These results could suggest that a moderate block of D-2 receptors enhances memory acquisition but blocking D-1 receptors affects it in an opposite way.

Animals↗

The relationship of dopamine receptor blockade to clinical response in schizophrenic patients treated with pimozide or haloperidol.

Pimozide and haloperidol were found to be equally effective in the treatment of acute schizophrenia in a double-blind clinical trial involving 22 patients. Drug plasma levels measured by radioimmunoassay (RIA) did not correlate with clinical response following either drug. Nor was there any correlation between clinical response and the dopamine receptor blocking activity of either drug as measured by radio receptor assay (RRA). Following pimozide plasma prolactin (PRL) levels correlated with clinical change, although the time courses of response of PRL and clinical response were dissimilar. There was no correlation between PRL and clinical response to haloperidol. RRA and RIA values correlated highly following pimozide but not haloperidol. Our findings lead us to conclude that the RRA technique reflects the plasma level of a drug rather than its central dopamine blocking activity. We also consider that the clinical response to antipsychotic drugs in schizophrenia may be less directly linked to dopamine receptor blockade than has previously been supposed.

Acute Disease↗

Tardive dyskinesia treated with pimozide.

We have investigated the action of pimozide in tardive dyskinesia induced by prolonged administration of phenothiazines. Improvement was recorded in a double blind study of 18 patients treated with maximum tolerated dosage (mean 18.8 mg/day) for 6 weeks. There was no deterioration in the therapeutic action of pimozide over this time. Parkinsonism and sedation were the main adverse effects. They were corrected by reduction of the dose of pimozide, but often recurred so that further adjustments of dosage were necessary. Our findings support the view that tardive dyskinesia is produced by a disturbance in the balance of central transmitters such that dopaminergic transmission is increased.

Aged↗

Performance effects with repeated-response measures during pimozide-produced dopamine receptor blockade.

Rats were trained to lever-press for either food reward or brain-stimulation reward on a continuous reinforcement schedule. Following training each animal was extinguished (i.e. tested with the reward omitted) under the influence of pimozide (0.25 mg/Kg or 0.5 mg/Kg). Pimozide produced a dose-dependent reduction in the mean number of responses to extinction made by rats in ecach group. In a second experiment, pimozide produced a similar dose-dependent decrease in the performance of a naturally occurring behavior (nose-poking) that had never been associated with reward. These data suggest that dopamine receptor blockade can produce a perofrmance deficit in situations which require repetitive responses, and that this deficit is unrelated to the presence or absence of reward.

Animals↗

Effects of pimozide on accuracy of performance and distribution of correct responding on a simultaneous discrimination task in the rat.

After training rats in a simultaneous discrimination problem, pimozide, a dopamine receptor blocker, was administered to determine whether accuracy of performance would be disrupted. Each animal received five doses of pimozide (vehicle, 0.05, 0.10, 0.30, and 0.60 mg/kg) delivered in a Latin Square sequence with five non-drug days between injections. Pimozide did not disrupt well established discrimination behavior at any of the doses even though a decrease in rate of responding was observed at the two higher doses. These results provide additional evidence that DA neutrons are not essential in the mediation of previously learned associations.

Animals↗

Pimozide attenuates conditioned taste preferences induced by self-stimulation in rats.

Conditioned taste preferences (CTPs) were observed in rats who drank flavored water followed by a session of self-stimulation. Control groups that did not self-stimulate did not exhibit CTPs. Other taste/SS pairings conducted under the influence of the dopamine receptor antagonist pimozide (0.1 or 0.3 mg/kg, IP) resulted in dose-dependent reduction in the size of the CTPs. No evidence of any aversive effects (conditioned taste aversions) of the pimozide treatment were observed in the no-stimulation control groups. These data suggest that, in addition to its effects on responding, low doses of pimozide reduce the rewarding properties of self-stimulation.

Animals↗

Pimozide blocks reinforcement but not priming from MFB stimulation in the rat.

When given non-contingent pretrial stimulation (priming stimulation) rats ran an alley for brain-stimulation reward faster than when there was no priming. This is one manifestation of the priming effect of rewarding stimulation. After treatment with the neuroleptic, pimozide, the first few trials fell in the range of normal primed performance when the rats were primed, and in the range of normal unprimed performance when they were not. In either case, an extinction-like decline in performance occurred after the first few trials. Run in a T-maze with water in one arm and a lever producing brain stimulation reward in the other, thirsty rats chose the stimulation reward when primed and the water reward when unprimed. Pimozide in doses that produced extinction of Skinner box responding did not alter this effect of priming on reward preference. These results demonstrate that the priming effect is unaltered by doses of pimozide that block the reinforcing effect of the stimulation.

Animals↗